T.A. Plunkett

Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer

Stephen Houston, T.A. Plunkett, D M Barnes et al. · British Journal of Cancer · 1999 · 220 citations · Full text

Medicine, Endocrinology, Oncology +16

Risk of complications from bone metastases in breast cancer

T.A. Plunkett, Paul Smith, R.D. Rubens · European Journal of Cancer · 2000 · 171 citations

Medicine, Oncology, Surgery +14

Metastatic eccrine porocarcinoma: Response to docetaxel (Taxotere) chemotherapy

T.A. Plunkett, A M Hanby, D.W. Miles et al. · Annals of Oncology · 2001 · 79 citations

Medicine, Oncology, Pharmacology +10

Form and pattern of MUC1 expression on T cells activated <i>in vivo</i> or <i>in vitro</i> suggests a function in T‐cell migration

Isabel Corrêa, T.A. Plunkett, Anda Vlad et al. · Immunology · 2003 · 71 citations · Full text

Life Sciences, Immunology, Oncology +17

Protection against MUC1 expressing mouse tumours by intra‐muscular injection of MUC1 cDNA requires functional CD8⁺ and CD4⁺ T cells but does not require the MUC1 tandem repeat domain

T.A. Plunkett, Rosalind Graham, Isobel Correa et al. · International Journal of Cancer · 2004 · 20 citations · Full text

Medicine, Immunology, Oncology +12